💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

St. Jude forms cyber panel after claims of heart-device bugs

Published 10/17/2016, 04:50 PM
© Reuters. The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the NYSE
ABT
-

By Jim Finkle

(Reuters) - Medical-device maker St. Jude Medical Inc said on Monday that it planned to set up a medical advisory board focused on cyber-security issues affecting patient care and safety.

St. Jude said in a statement that the group, known as the Cyber Security Medical Advisory Board, would provide advice on cyber security standards for medical devices.

The St. Paul, Minnesota-based company is establishing the group as the U.S. Food and Drug Administration investigates claims that St. Jude heart devices are riddled with defects that make them vulnerable to fatal cyber hacks.

The FDA launched that probe in August after short-seller Muddy Waters and cyber research firm MedSec Holdings said they had placed bets that St. Jude shares would fall after they discovered the alleged vulnerabilities.

“We take the cyber security of our devices very seriously and creating the Cyber Security Medical Advisory Board is one more demonstration of our ongoing commitment to advancing standards of patient care around the world without comprising safety and security,” St. Jude Chief Medical Officer Mark Carlson said in a statement.

The board, whose membership has yet to be finalized, will work with technology experts at St. Jude Medical as well as external researchers to help "maintain and enhance cyber security and patient safety,” Carlson said.

Suzanne Schwartz, a senior official in the FDA's Center for Devices and Radiological Health, said the agency supports efforts by medical device manufacturers to prioritize cyber security.

"Doing so in collaboration with other stakeholders such as cyber security researchers, health care providers, patients and government agencies, means cyber security vulnerabilities are more likely to be identified, assessed and fixed in a timely manner before they can cause patient harm," she said in a statement.

St. Jude agreed in April to sell itself for $25 billion to Abbott Laboratories (NYSE:ABT).

© Reuters. The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the NYSE

The company last week said it would recall some of its 400,000 implanted heart devices due to risk of premature battery depletion, a condition linked to two deaths in Europe.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.